The evidence generation trap: 5 questions pharma leaders should ask before building again
Five questions to help pharma leaders stop rebuilding RWE studies and create reusable evidence foundations for the next decision.
Resources and expert insights
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Viewing results for:
Filter by type
Filter by topic
Search
Read more
Infographic – Building trusted research environments that scale
A visual guide to trusted research environments, from governance and security to scalable operations.
Infographic – Turn distributed data into decision-ready evidence
A visual guide to federated analytics and learning, showing how to transform distributed data into trusted, decision-ready evidence.
Infographic – Turn fragmented real-world data into decision-ready evidence
A visual overview of evidence readiness and the capabilities needed to generate trusted, reusable evidence at scale.
Using real-world evidence to pressure-test oncology target product profiles
Real-world evidence can help teams pressure-test target product profiles and guide the next investment decision.
How federated analytics enables decision-ready evidence in pharma
Discover how federated analytics helps pharma generate trusted, decision-ready evidence while enabling scalable, privacy-preserving research.
What’s next for clinical trials? Exploring the rise of personalized research
From AI readiness to federated data networks, Mukhtar Ahmed discusses the trends shaping evidence generation and the rise of personalized research.
Building a reusable evidence foundation for confident decision-making
Move beyond one-off studies with a reusable evidence foundation designed for trusted, decision-ready evidence.
Fit-for-purpose data, decision-ready insights: A conversation with Narasimha Kumar and Tobi Oremulé
Narasimha Kumar and Tobi Oremulé discuss fit-for-purpose data, reusable evidence foundations, and decision-ready evidence.